Can ETF Securities’ CURE ETF Breathe Life Into Your Portfolio?
The ETFS S&P Biotech ETF (ASX:CURE) is one of the more novel ETFs on the ASX but it has got off to healthy start (pun intended). Below, I’ll list some of the strengths and risks for CURE.
AMP Shares Sink 8% On Dividend, Takeover News
The AMP Limited (ASX:AMP) share price fell 8% today following news that it may scrap its interim dividend to shareholders with uncertainty over the Resolution Life takeover of its Life business.
Can The Vanguard Fixed Interest ETF (ASX:VAF) Continue To Rise?
The Vanguard Australian Fixed Interest Index ETF (ASX: VAF) has performed strongly as falling bond yields have surprised economists and investors alike.
Check out our ETF Strategy + portfolio for ‘no fuss’ investing!